Signe Bergliot Nielsen

I am proud to announce, on behalf of the DAHANCA group, that our national phase IV study on cancer of unknown primary in the head and neck is out! 📣📣 We thoroughly evaluated the current Danish management strategy of this complicated disease. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

A pleasure for me to participate in #ECHNO2025 in Amsterdam, gathering experts in head and neck cancer. Thank you for interesting discussions after my talk in the DAHANCA session on TBM by TORS in HNSCCUP. Also, congratulations to @SomiahSiddiq for a brilliant review on the topic

@SixtenHarborg @AndersMlby @cancer_dk @LancetRH_Europe Congratulations on the great paper, Anders!

@AndersMlby @cancer_dk @LancetRH_Europe Beautiful @AndersMlby ! Congratulations on the publication and your important work 👏🏻

📢 DBCG IMN2 publication Internal mammary node irradiation improves survival in node-positive #BreastCancer patients treated with newer systemic therapies and 3D-based #radiotherapy 📖 Open-access article: thelancet.com/journals/lanep… #DBCG @cancer_dk @LancetRH_Europe #radonc

@claire_paters0n Dear Claire. Thank you for the question, which is highly relevant as these patients go through extensive work-up. The present study does not answer that question. Luckily, we adressed that in another study which is soon to be published. I will make a announcement when it's out.

@SigneBergliot Nice work, tbanks for sharing. Do you think omitting the EUA/tonsillectomy/BoT/NP biopsies & going straight to TORS/TBM (& tonsillectomy) would be appropriate?

Our national study presenting the largest cohort of patients with head and neck cancer of unknown primary (HNSCCUP) undergoing tongue base mucosectomy after guideline based work-up is now published! Please take a look. sciencedirect.com/science/articl…

Welcoming everyone with an interest in head and neck cancer of unknown primary to participate in my PhD defence in Aarhus, on the 31st of May.

🗞️Publication alert! ✍️ I am happy to share that our dose plan study comparing protons vs. photons in the primary and recurrent setting of head and neck SCC of unknown primary is out. doi.org/10.1080/028418…

@oncaarhus @anne Amazing work, Anne-Mette! Looking forward to hear about your presentation!

🗣️Today @Anne-Mette Iversen proudly presented the results from the study on hand hygiene improvement among healthcare workers during the COVID-19 pandemic in Geneva🇨🇭💪🤩 #ICPIC2023 #Infection prevention #Geneva #oncaarhus

@oncaarhus You look very determined, guys! Have a nice course!

The danish participants at the target volume determination course in Prague . . . #oncaarhus #targetvolumedetermination #prague

@KristianQvist Pyh....jeg er virkelig glad for at der ikke skete jer noget! Det er SÅ utroligt farligt! "Kør bil, når du kører bil!" ☝️😳

Trak helt ud i rabatten og klodsede bremserne, var det alene held, der sørgede for, at den modkørende genvandt kontrollen og styrede udenom os i absolut sidste øjeblik så katastrofen blev undgået.

Please, lad nu mobilen og andre devices passe sig selv når du skal forestille at køre bil. I formiddag var jeg, min hustru og vores to børn 1-2 meter fra at blive torpederet af en modkørende bilist. Vejen svingede blødt, men den modkørende fortsatte sin bane ligeud. Selvom vi

@claire_paters0n @ESTRO_RT @oncaarhus Thank you! 🙏

@SigneBergliot @ESTRO_RT @oncaarhus Really enjoyed your presentation, thank you 👏🏻

Yesterday was a big! On behalf of the DAHANCA group, I had the great honor to present the results of our point of origin based pattern of failure study on IMRT treated patients with cancer of unknown primary in the head and neck (HNSCC CUP) at ESTRO @ESTRO_RT @oncaarhus

@aallam_mo @ESTRO_RT @oncaarhus Exactly! And I feel that the more I dig into this area of ​​interest, the more exciting the mystery of the unknown becomes!

@VinPaleri @ESTRO_RT @oncaarhus Yet unpublished, but will be published soon. Data shows that the point of origins of the nodal failures in overall are lying within the high dose areas, i.e. by the bilateral elective neck approach we "hit the target". However, mucosal failures is another story...

@SigneBergliot @ESTRO_RT @oncaarhus Is this published? If not, can you offer a summary here?

@SomiahSiddiq @ESTRO_RT @oncaarhus Thank you Somiah!

@SigneBergliot @ESTRO_RT @oncaarhus Congrats, really pleased to see this!!

@KrauseProf @ESTRO_RT @oncaarhus Thank you Professor Krause.

@SigneBergliot @ESTRO_RT @oncaarhus I watched that as Video in the conference app, very good talk and important topic.

@duvvuri_md @ESTRO_RT @oncaarhus Will be published soon.

@SigneBergliot @ESTRO_RT @oncaarhus Look forward to seeing the results. Important problem

Thrilled by Trine Tramm's presentation on hos immunity and tumour microenvironment as a predictor of RT. Trine has excellent communication skills and her research is outstanding! #ESTRO23

@oncaarhus @AUHdk Sharing our knowledge, is one of the most important weapons we have in the fight against cancer. ESTRO is the place where researchers meet and equip together. I'm proud to have been a part of this year's most powerful exchange of experiences!

#estro2022 #CancerResearch @AUHdk